Report cover image

Nuclear Medicine Market, By Type (Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, PET Radiopharmaceuticals and Therapeutic Nuclear Medicine Alpha Emitters, Beta Emitters, Brachytherapy Isotopes), By Application (Oncology, Cardiology, Neurology, E

Publisher Coherent Market Insights
Published Jun 02, 2025
Length 165 Pages
SKU # CMI20173578

Description

The Global Nuclear Medicine Market is estimated to be valued at USD 18.32 Bn in 2025 and is expected to reach USD 38.52 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032. The global nuclear medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in nuclear medicine technology, and the growing demand for personalized medicine. Nuclear medicine involves the use of radioactive substances for diagnostic and therapeutic purposes, enabling the early detection and treatment of various diseases, including cancer, cardiovascular disorders, and neurological conditions. The market encompasses a wide range of products and services, such as radiopharmaceuticals, imaging equipment, and software solutions, catering to the diverse needs of healthcare professionals and patients worldwide. As the healthcare industry continues to evolve and embrace innovative technologies, the nuclear medicine market is poised for further expansion and development in the coming years.

Market Dynamic

The global nuclear medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of chronic diseases, such as cancer and cardiovascular disorders, which require advanced diagnostic and therapeutic interventions. Additionally, the growing geriatric population worldwide is expected to fuel the demand for nuclear medicine procedures, as older individuals are more susceptible to age-related diseases. Technological advancements, including the development of hybrid imaging modalities and the introduction of novel radiopharmaceuticals, are also driving market growth by improving the accuracy and efficiency of nuclear medicine procedures. However, the market faces certain restraints, such as the high cost of nuclear medicine equipment and the stringent regulatory requirements for the approval and use of radiopharmaceuticals. The shortage of skilled professionals trained in nuclear medicine techniques also poses a challenge to market growth. Despite these restraints, the nuclear medicine market presents significant opportunities for growth, particularly in emerging economies, where there is a rising demand for advanced healthcare services. The increasing adoption of nuclear medicine in the diagnosis and treatment of neurological disorders, such as Alzheimer's and Parkinson's disease, is another promising opportunity for market expansion.

Key Features of the Study
  • This report provides in-depth analysis of the global nuclear medicine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global nuclear medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Bracco Imaging, Canon Medical Systems, Eczacıbaşı-Monrol, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging, Bayer AG, RadioMedix, IBA Radiopharma Solutions, Nordion (a Sotera Health company), Advanced Accelerator Applications, and Actinium Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine market
Market Segmentation
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • I-123
  • Tl-201
  • Ga-67
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • Rb-82
  • Other PET Isotopes
  • Therapeutic Nuclear Medicine
  • Alpha Emitters
  • Ra-223
  • Beta Emitters
  • I-131
  • Y-90
  • Sm-153
  • Lu-177
  • Re-186
  • Other Beta Emitters
  • Brachytherapy Isotopes
  • Cesium-131
  • Iodine-125
  • Palladium-103
  • Iridium-192
  • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Bone Metastasis
  • Gastroenterology
  • Pulmonology
  • Infectious Diseases
  • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals & Clinics
  • Diagnostic Centers
  • Research Laboratories
  • Academic Institutions
  • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Toshiba Medical Systems
  • Bracco Imaging
  • Canon Medical Systems
  • Eczacıbaşı-Monrol
  • Mallinckrodt Pharmaceuticals
  • Lantheus Medical Imaging
  • Bayer AG
  • RadioMedix
  • IBA Radiopharma Solutions
  • Nordion (a Sotera Health company)
  • Advanced Accelerator Applications
  • Actinium Pharmaceuticals

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Nuclear Medicine Market, By Type
Global Nuclear Medicine Market, By Application
Global Nuclear Medicine Market, By End User
Global Nuclear Medicine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Nuclear Medicine Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Diagnostic Nuclear Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
SPECT Radiopharmaceuticals
Tc-99m
I-123
Tl-201
Ga-67
Other SPECT Isotopes
PET Radiopharmaceuticals
F-18
Rb-82
Therapeutic Nuclear Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Alpha Emitters
Ra-223
Beta Emitters
I-131
Y-90
Sm-153
Lu-177
Re-186
Other Beta Emitters
Brachytherapy Isotopes
Cesium-131
Iodine-125
Palladium-103
Iridium-192
Others
5. Global Nuclear Medicine Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bone Metastasis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastroenterology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pulmonology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Nuclear Medicine Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Nuclear Medicine Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Siemens Healthineers
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GE Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Philips Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Toshiba Medical Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bracco Imaging
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Canon Medical Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Eczacıbaşı-Monrol
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mallinckrodt Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Lantheus Medical Imaging
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
RadioMedix
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
IBA Radiopharma Solutions
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Nordion (a Sotera Health company)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Advanced Accelerator Applications
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Actinium Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on 'Nuclear Medicine Market' - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us